Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy: an independent risk factor.

F H Messerli1, R Ketelhut

  • 1Department of Internal Medicine, Ochsner Clinic, New Orleans, LA 70121.

Journal of Cardiovascular Pharmacology
|January 1, 1991
PubMed
Summary

Left ventricular hypertrophy (LVH) significantly increases cardiovascular risks. Reducing LVH through antihypertensive therapy shows promise, but further studies are needed to confirm clinical benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urocortin 2 - a protective effect in hypertension?

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2023
Same author

In vitro fertilization exacerbates stroke size and neurological disability in wildtype mice.

International journal of cardiology·2021
Same author

More SPRINT controversy.

Journal of internal medicine·2017
Same author

Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?

Hipertension y riesgo vascular·2015
Same author

[Fixed dose combination of an ARB calcium antagonist lowers blood pressure effectively and improves quality of life].

MMW Fortschritte der Medizin·2011
Same author

Cardioprotection with beta-blockers: myths, facts and Pascal's wager.

Journal of internal medicine·2009

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathophysiology

Background:

  • Left ventricular hypertrophy (LVH) is a marked increase in left ventricle muscle mass.
  • LVH is a potent predictor of cardiovascular morbidity and mortality.
  • It elevates risks for myocardial infarction, heart failure, and sudden death six- to eightfold.

Purpose of the Study:

  • To review the pathophysiology and clinical implications of LVH.
  • To discuss the impact of LVH on cardiac function and oxygen demand.
  • To explore the potential of antihypertensive therapy in managing LVH.

Main Methods:

  • Review of existing literature on LVH.
  • Analysis of factors contributing to increased hemodynamic burden.
  • Evaluation of the effects of antihypertensive treatments.

Related Experiment Videos

Main Results:

  • LVH impairs coronary reserve, increases cardiac oxygen needs, and affects ventricular filling and contractility.
  • Conditions like hypertension, obesity, and valvular heart disease contribute to LVH.
  • Antihypertensive therapy can potentially reduce LVH and its consequences.

Conclusions:

  • LVH poses a significant threat to cardiovascular health.
  • Therapeutic interventions targeting blood pressure may mitigate LVH.
  • Further epidemiological research is essential to validate the clinical advantages of LVH reduction.